• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含硫柳汞疫苗与自闭症:近期流行病学研究综述

Thimerosal-containing vaccines and autism: a review of recent epidemiologic studies.

作者信息

Hurley Anne M, Tadrous Mina, Miller Elizabeth S

机构信息

Department of Clinical Pharmacy, College of Pharmacy, The University of Tennessee Health Science Center, Memphis, Tennessee.

出版信息

J Pediatr Pharmacol Ther. 2010 Jul;15(3):173-81.

PMID:22477809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3018252/
Abstract

Although epidemiologic evidence has not supported the hypothesis of a causal relationship between thimerosal-containing vaccines and autism, concerns continue about pediatric exposure to mercury through vaccine administration. A statement issued by the American Academy of Pediatrics and the US Public Health Service in 1999 prompted the removal of thimerosal from many vaccines. In 2004, the Immunization Safety Review Committee of the Institute of Medicine rejected the hypothesis of a causal relationship between thimerosal-containing vaccines and autism.In a search of MEDLINE and EMBASE, we identified articles that address the potential association between thimerosal and neurodevelopmental disorders, specifically autism. In this article, we review recent pharmacokinetic and epidemiologic studies published between 2003 and 2008 regarding the proposed link between thimerosal and autism.

摘要

尽管流行病学证据并不支持含硫柳汞疫苗与自闭症之间存在因果关系的假说,但人们仍对儿童通过接种疫苗接触汞的情况感到担忧。1999年美国儿科学会和美国公共卫生服务局发布的一份声明促使许多疫苗中不再使用硫柳汞。2004年,医学研究所的免疫安全审查委员会驳回了含硫柳汞疫苗与自闭症之间存在因果关系的假说。在检索MEDLINE和EMBASE时,我们识别出了探讨硫柳汞与神经发育障碍(特别是自闭症)之间潜在关联的文章。在本文中,我们回顾了2003年至2008年间发表的有关硫柳汞与自闭症之间假定联系的最新药代动力学和流行病学研究。

相似文献

1
Thimerosal-containing vaccines and autism: a review of recent epidemiologic studies.含硫柳汞疫苗与自闭症:近期流行病学研究综述
J Pediatr Pharmacol Ther. 2010 Jul;15(3):173-81.
2
Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data.含硫柳汞疫苗与自闭症谱系障碍:对已发表原始数据的批判性综述
Pediatrics. 2004 Sep;114(3):793-804. doi: 10.1542/peds.2004-0434.
3
Summary of the joint statement on thimerosal in vaccines. American Academy of Family Physicians, American Academy of Pediatrics, Advisory Committee on Immunization Practices, Public Health Service.
MMWR Morb Mortal Wkly Rep. 2000 Jul 14;49(27):622, 631.
4
Recommendations regarding the use of vaccines that contain thimerosal as a preservative.关于使用含硫柳汞作为防腐剂的疫苗的建议。
MMWR Morb Mortal Wkly Rep. 1999 Nov 5;48(43):996-8.
5
An assessment of thimerosal use in childhood vaccines.对儿童疫苗中硫柳汞使用情况的评估。
Pediatrics. 2001 May;107(5):1147-54. doi: 10.1542/peds.107.5.1147.
6
A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism.含硫柳汞的儿童疫苗中MMR免疫接种和汞剂量对自闭症人群患病率影响的比较评估。
Med Sci Monit. 2004 Mar;10(3):PI33-9. Epub 2004 Mar 1.
7
8
Autism and thimerosal-containing vaccines: lack of consistent evidence for an association.自闭症与含硫柳汞疫苗:缺乏存在关联的一致证据。
Am J Prev Med. 2003 Aug;25(2):101-6. doi: 10.1016/s0749-3797(03)00113-2.
9
Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service.
MMWR Morb Mortal Wkly Rep. 1999 Jul 9;48(26):563-5.
10
An assessment of downward trends in neurodevelopmental disorders in the United States following removal of Thimerosal from childhood vaccines.
Med Sci Monit. 2006 Jun;12(6):CR231-9. Epub 2006 May 29.

引用本文的文献

1
Cancer cell-intrinsic biosynthesis of itaconate promotes tumor immunogenicity.细胞内源性合成衣康酸促进肿瘤免疫原性。
EMBO J. 2024 Nov;43(22):5530-5547. doi: 10.1038/s44318-024-00217-y. Epub 2024 Sep 30.
2
Environmental Risk Factors in Autism Spectrum Disorder: A Narrative Review.自闭症谱系障碍的环境风险因素:叙事性综述。
Curr Med Chem. 2024;31(17):2345-2360. doi: 10.2174/0109298673252471231121045529.
3
Quantitative Investigation on Exposure to Potentially Harmful Excipients by Injection Drug Administration in Children Under 2 Years of Age and Analysis of Association with Adverse Events: A Single-Center, Retrospective Observational Study.儿童 2 岁以下人群注射用药时潜在有害辅料暴露的定量研究及其与不良事件的关联分析:一项单中心、回顾性观察研究。
Ther Innov Regul Sci. 2024 Mar;58(2):316-335. doi: 10.1007/s43441-023-00596-0. Epub 2023 Dec 6.
4
How to Respond to Misinformation From the Anti-Vaccine Movement.如何应对反疫苗运动中的错误信息。
Inquiry. 2023 Jan-Dec;60:469580231155723. doi: 10.1177/00469580231155723.
5
A Role for Gene-Environment Interactions in Autism Spectrum Disorder Is Supported by Variants in Genes Regulating the Effects of Exposure to Xenobiotics.调节外源性物质暴露影响的基因变异支持了基因-环境相互作用在自闭症谱系障碍中的作用。
Front Neurosci. 2022 May 19;16:862315. doi: 10.3389/fnins.2022.862315. eCollection 2022.
6
COVID-19 Anti-Vaccine Sentiments: Analyses of Comments from Social Media.新冠病毒疫苗抵制情绪:社交媒体评论分析
Healthcare (Basel). 2021 Nov 9;9(11):1530. doi: 10.3390/healthcare9111530.
7
Biological properties the novel application of N-trimethyl chitosan nanospheres as a stabilizer and preservative in tetanus vaccine.新型N-三甲基壳聚糖纳米球作为破伤风疫苗稳定剂和防腐剂的生物学特性及应用
Clin Exp Vaccine Res. 2021 Jan;10(1):24-34. doi: 10.7774/cevr.2021.10.1.24. Epub 2021 Jan 31.
8
The Changing Epidemiology of Autism Spectrum Disorders.自闭症谱系障碍不断变化的流行病学特征。
Annu Rev Public Health. 2017 Mar 20;38:81-102. doi: 10.1146/annurev-publhealth-031816-044318. Epub 2016 Dec 21.
9
Effects of Thimerosal on Lipid Bilayers and Human Erythrocytes: An In Vitro Study.硫柳汞对脂质双层膜和人类红细胞的影响:一项体外研究。
J Membr Biol. 2016 Dec;249(6):823-831. doi: 10.1007/s00232-016-9933-y. Epub 2016 Oct 13.
10
Fingerprinting of neurotoxic compounds using a mouse embryonic stem cell dual luminescence reporter assay.使用小鼠胚胎干细胞双荧光报告基因检测法对神经毒性化合物进行指纹识别。
Arch Toxicol. 2017 Jan;91(1):365-391. doi: 10.1007/s00204-016-1690-2. Epub 2016 Mar 25.

本文引用的文献

1
Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink.婴儿硫柳汞暴露与神经发育障碍:疫苗安全数据链中计算机化医疗记录的评估
J Neurol Sci. 2008 Aug 15;271(1-2):110-8. doi: 10.1016/j.jns.2008.04.002. Epub 2008 May 15.
2
Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines.接种含硫柳汞疫苗后新生儿和婴儿体内的汞含量。
Pediatrics. 2008 Feb;121(2):e208-14. doi: 10.1542/peds.2006-3363.
3
Continuing increases in autism reported to California's developmental services system: mercury in retrograde.向加利福尼亚州发展服务系统报告的自闭症病例持续增加:水星逆行。 (注:此句中“mercury in retrograde”在医学语境外可能是一种隐喻或带有特定文化背景含义的表达,单从字面看与医学关联不大,译文按原文逐字翻译)
Arch Gen Psychiatry. 2008 Jan;65(1):19-24. doi: 10.1001/archgenpsychiatry.2007.1.
4
Mercury exposure and public health.汞暴露与公众健康。
Pediatr Clin North Am. 2007 Apr;54(2):237-69, viii. doi: 10.1016/j.pcl.2007.02.005.
5
Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations.加拿大魁北克省蒙特利尔市的广泛性发育障碍:患病率及其与免疫接种的关联
Pediatrics. 2006 Jul;118(1):e139-50. doi: 10.1542/peds.2005-2993.
6
Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association.婴儿硫柳汞暴露与发育障碍:英国的一项回顾性队列研究不支持因果关联。
Pediatrics. 2004 Sep;114(3):584-91. doi: 10.1542/peds.2003-1177-L.
7
Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United kingdom does not support a causal association.婴儿暴露于硫柳汞与发育障碍:英国的一项前瞻性队列研究不支持因果关联。
Pediatrics. 2004 Sep;114(3):577-83. doi: 10.1542/peds.2003-1176-L.
8
Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases.含硫柳汞疫苗的安全性:对计算机化健康维护组织数据库的两阶段研究。
Pediatrics. 2003 Nov;112(5):1039-48.
9
The toxicology of mercury--current exposures and clinical manifestations.汞的毒理学——当前暴露情况及临床表现
N Engl J Med. 2003 Oct 30;349(18):1731-7. doi: 10.1056/NEJMra022471.
10
Association between thimerosal-containing vaccine and autism.含硫柳汞疫苗与自闭症之间的关联。
JAMA. 2003 Oct 1;290(13):1763-6. doi: 10.1001/jama.290.13.1763.